Zions Bancorporation, National Association (ZION) — Fair Value Analysis

Base-case fair value (P50): $156.15 · Current price: $62.50 · Verdict: Undervalued

The Verdict on ZION

Based on Monte Carlo simulations, ZIONS BANCORPORATION (ZION) is currently rated as Deeply Undervalued. The current market price of $62.50 stands in stark contrast to our median fair value (P50) estimate of $156.15. This substantial discrepancy implies a potential upside of +149.8% from its current trading level, suggesting a significant mispricing by the market. Our quantitative models consistently point to this considerable undervaluation.

How ZION stacks up against peers

While ZION presents a compelling valuation case, its quality tier remains unrated at this time. This 'unrated' status signifies that a comparative assessment of its operational and financial health against sector peers is not currently provided within our framework. Despite the lack of a quality rating, the sheer magnitude of the valuation gap—a +149.8% difference between the current price ($62.50) and the P50 ($156.15)—is a primary driver of its deeply undervalued verdict. Investors should note this distinction between fundamental quality assessment and pure valuation opportunity.

What this means for investors

The pronounced Deeply Undervalued verdict for ZION, with a median fair value of $156.15 implying a +149.8% gain from its current price of $62.50, suggests a significant investment opportunity. The Monte Carlo analysis highlights the potential for substantial upside, even without a specific quality tier rating to contextualize its operational health against peers. Investors considering ZION should weigh this substantial valuation discrepancy. For a comprehensive view of ZION's full bear and bull case distribution and to track its fair value as new fundamentals are released, sign up for a free FairCurve account.